Viagra linked to reduced Alzheimer's risk: Findings from University College London Study

The favorable impact of Viagra in reducing the risks of Alzheimer's disease was observed two years ago.

This hypothesis has now been substantiated in a fresh study conducted by academics from University College London. The research encompassed roughly 270 thousand men who were diagnosed with erectile dysfunction and had hitherto not reported cognitive difficulties.

The study's results indicated that men who were prescribed erectile dysfunction treatments like Viagra and Cialis were 18 percent less likely to develop Alzheimer's disease.

Medics also identified that the positive correlation between the medications and a reduced Alzheimer's risk was more pronounced among the individuals who were prescribed them most frequently.

"Further studies are needed to validate these results, further investigate these drugs' potential advantages and mechanisms, and determine the ideal dosage," highlighted Dr Ruth Brauer from the University College London School of Pharmacy.

She further mentioned the necessity now to investigate how these drugs perform for both sexes. Specialists emphasized that the findings of this research cannot yet confirm if Viagra and similar drugs protect against Alzheimer's disease, but they are encouraged by the outcomes.

Researchers made equivalent interpretations from the University of Oxford. "This is a noteworthy progression, as the adaptation of existing medications to prevent dementia is a promising strategy," stated Dr Ivan Koychev, senior clinical researcher from the institution.